This pathway is highly activated in α-SMA+ CAFs isolated from human PDAC resections, and when SOM-230 was administered to mice engrafted with human PDAC there was a reduction in tumour growth and chemoresistance to gemcitabine. Here, ACTA1 is linked to neoplasm.